The Middle East and Africa medical writing market is expected to reach US$ 254.84 million by 2027 from US$ 156.02 million in 2019; it is anticipated to grow at a CAGR of 6.3% from 2020 to 2027. The growth of the Middle East and Africa medical writing market is driven by the high growth in research and development, and massive government support to the healthcare sector. However, challenges associated with medical writers restrain the market growth. Medical writers combine their scientific knowledge and research skills to draft the information and present it to the intended audience.Medical writing is an integral part in drug development process.
Medical writers are employed in contract research organizations (CROs), pharmaceutical companies, and communications agencies.They are also hired by pharmacological companies to develop required doctuments to gain registration from international regulatory authorities for their products.
Medical writers play an essential role in the preparation of various medical documents such as organizational protocols and final reports of clinical trials, regulatory submissions, and clinical expert reports. They also help in the preparation of manuscripts to be published in medical journals.The Drug Discovery and Development Research Unit of the Institute of Infectious Disease and Molecular Medicine (IIDMM), the University of Cape Town, specializes in drug development. It focuses on the development of drugs against diseases, which are prominent among Africans. The medical writers associated with drug development projects in South Africa assist in the preparation of documents to be submitted to regulatory bodies. Thus, the growth in research and development activities is driving the Middle East and Africa medical writing market. Being one of the world’s less developed regions, the Middle East and Africa is facing severe impact of the COVID-19 pandemic.Health authorities across the region are worrying that the attempts of fighting the outbreak would indirectly cause the deaths of cancer patients, gynecology patients, and other chronic diseases patients due to lack of hospital admissions and availability of medical staff.
The death count of patients suffering from other diseases in low-income regions is increasing as healthcare professionals have redirected their efforts toward COVID-19 management due to the availability of limited resources and staff.In this pandemic emergency, governments are taking measures to help patients; also, doctors are now consulting their patients over a phone call or video call than in person consultation.
Further, people are rescheduling their elective surgeries due to the COVID-19 crisis. Based on type,theMiddle East and Africa medical writing market is segmented intoregulatory writing, clinical writing, scientific writing, and others.The clinical writing segment held the largest share of the market in 2019.
However,the regulatory writing segment is anticipated to register the highest CAGR in the market during 2020-2027. Based onapplication, the Middle East and Africa medical writing market is segmented into medical journalism, medical education, medico marketing, and others. The medical education segment held the largest market share in 2019, whereas the medico marketing segment is anticipated to register the highest CAGR in the market during the forecast period. The Middle East and Africa medical writing market, by end user, is segmented into pharmaceutical and biotechnological companies, contract research organizations (CROs), and others. The pharmaceutical and biotechnological segment held the largest market share in 2019, and the same segment is anticipated to register the highest CAGR in the market from 2020 to 2027. A few of the primary and secondary sources referred to while preparing the report on the Middle East and Africa medical writing market are the Saudi FDA (SFDA), and the Institute of Infectious Disease and Molecular Medicine (IIDMM).
Our reports have been used by over 10K customers, including:
The Global Discovery Stage Partnering Terms and Agreements in Pharma and Biotech 2014-2021 report. The report provides a detailed understanding and analysis of how, why and on what terms companies enter discovery stage partnering deals. These deals are discovery stage whereby the licensee obtains a right or an option...
The Middle East & Africa organoids market is expected to reach US$ 141.26 million in 2027 from US$ 37.34 million in 2019; the market is estimated to grow at a CAGR of 20.9% from 2020 to 2027. The growth of the market can be attributed to growing research on organoids in the Middle East & Africa region and rising focus on developing alternatives...
Global Glycobiology Market, By Product (Enzymes, Instruments, Reagents and Kits), By Application (Drug Discovery, Disease Diagnostics, Virology, Cell Biology, Oncology, Others), By End User (Research Institutes, Diagnostic Centers, Hospitals, Clinical Laboratories, Pharmaceutical & Biotechnology Companies, Others), By Region, Competition,...
India Stem Cell Market, By Product Type (Adult; Induced Pluripotent; Human Embryonic; Others), By Application (Regenerative Medicine Vs. Drug Discovery & Development), By End User (Pharmaceutical/Biotechnology Companies, CRO) By Technology (Cell Acquisition; Cell Production; Cryopreservation; Expansion & Subculture), By Region, Competition...
C5a Anaphylatoxin Chemotactic Receptor 1 - Pipeline Review, H2 2020
C5a Anaphylatoxin Chemotactic Receptor 1 (CD88 or C5AR1) pipeline Target constitutes close to 9 molecules. Out of which approximately 7 molecules are developed by companies and remaining by the universities/institutes....
The South and Central America medical writing market is expected to reach US$ 362.35 million by 2027 from US$ 217.01 million in 2019; it is anticipated to grow at a CAGR of 6.6% from 2020-2027. The growth of South and Central America medical writing market is driven by the rising government support to the healthcare sector and increasing...
An organ-on-a-chip is a microfluidic cell culture device that contains continuously perfused chambers. This chip develops a narrow channel for the blood and airflow in organs, such as the lung, gut, liver, heart, and other organs. Such devices produce multiple levels of tissue and organ functionalities, which are not feasible using conventional...
200 pages •
By The Business Research Company
• Dec 2020
Major players in the biosimilar therapeutic peptides market are Eli Lilly, Sanofi, Takeda Pharmaceuticals, Teva Pharmaceuticals, Pfizer Inc., Amgen Inc., AstraZeneca PLC, GlaxoSmithKline (GSK), Novartis AG and Novo Nordisk A/S. The global biosimilar therapeutic peptides market is expected to decline from $0.80 billion in 2019 to $0.77...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.